In recent years, Brazil has made tremendous advances in the field of biotechnology despite its status as a developing country. It has taken advantage of its public-sector infrastructure and low-cost production to tackle the issue of poor health care, which is one source of poverty, by investing heavily and soundly in health research and development to create and patent new vaccines, technologies, and health services to combat diseases that primarily affect the poor.
